vs

Side-by-side financial comparison of ALTISOURCE PORTFOLIO SOLUTIONS S.A. (ASPS) and AVADEL PHARMACEUTICALS PLC (AVDL). Click either name above to swap in a different company.

AVADEL PHARMACEUTICALS PLC is the larger business by last-quarter revenue ($77.5M vs $42.3M, roughly 1.8× ALTISOURCE PORTFOLIO SOLUTIONS S.A.). AVADEL PHARMACEUTICALS PLC runs the higher net margin — 0.0% vs -16.8%, a 16.9% gap on every dollar of revenue. On growth, AVADEL PHARMACEUTICALS PLC posted the faster year-over-year revenue change (54.9% vs 3.2%). AVADEL PHARMACEUTICALS PLC produced more free cash flow last quarter ($22.2M vs $-525.0K). Over the past eight quarters, AVADEL PHARMACEUTICALS PLC's revenue compounded faster (99.6% CAGR vs 3.6%).

Altisource Portfolio Solutions S.A. is a global provider of integrated technology, data and operational services for the mortgage, real estate and consumer finance sectors. It serves lenders, servicers and investors, offering solutions that streamline asset management and residential property transaction workflows to boost operational efficiency.

Avadel Pharmaceuticals, is an Irish specialty pharmaceutical company that focuses on sleep disorder medicines. Avadel markets products in the hospital and primary care spaces. The company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.

ASPS vs AVDL — Head-to-Head

Bigger by revenue
AVDL
AVDL
1.8× larger
AVDL
$77.5M
$42.3M
ASPS
Growing faster (revenue YoY)
AVDL
AVDL
+51.6% gap
AVDL
54.9%
3.2%
ASPS
Higher net margin
AVDL
AVDL
16.9% more per $
AVDL
0.0%
-16.8%
ASPS
More free cash flow
AVDL
AVDL
$22.7M more FCF
AVDL
$22.2M
$-525.0K
ASPS
Faster 2-yr revenue CAGR
AVDL
AVDL
Annualised
AVDL
99.6%
3.6%
ASPS

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ASPS
ASPS
AVDL
AVDL
Revenue
$42.3M
$77.5M
Net Profit
$-7.1M
$20.0K
Gross Margin
26.5%
Operating Margin
-15.5%
2.5%
Net Margin
-16.8%
0.0%
Revenue YoY
3.2%
54.9%
Net Profit YoY
18.2%
100.8%
EPS (diluted)
$-1.02
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPS
ASPS
AVDL
AVDL
Q4 25
$42.3M
Q3 25
$41.9M
$77.5M
Q2 25
$43.3M
$68.1M
Q1 25
$43.4M
$52.5M
Q4 24
$41.0M
$50.4M
Q3 24
$40.5M
$50.0M
Q2 24
$39.1M
$41.5M
Q1 24
$39.5M
$27.2M
Net Profit
ASPS
ASPS
AVDL
AVDL
Q4 25
$-7.1M
Q3 25
$-2.3M
$20.0K
Q2 25
$16.7M
$9.7M
Q1 25
$-5.3M
$-4.9M
Q4 24
$-8.7M
$-5.0M
Q3 24
$-9.3M
$-2.6M
Q2 24
$-8.3M
$-13.8M
Q1 24
$-9.2M
$-27.3M
Gross Margin
ASPS
ASPS
AVDL
AVDL
Q4 25
26.5%
Q3 25
27.1%
Q2 25
30.1%
90.7%
Q1 25
30.7%
89.4%
Q4 24
30.3%
90.5%
Q3 24
29.8%
87.7%
Q2 24
32.5%
93.3%
Q1 24
31.2%
94.4%
Operating Margin
ASPS
ASPS
AVDL
AVDL
Q4 25
-15.5%
Q3 25
1.2%
2.5%
Q2 25
7.5%
13.0%
Q1 25
7.5%
-5.7%
Q4 24
1.4%
-6.5%
Q3 24
2.7%
-0.7%
Q2 24
5.3%
-30.7%
Q1 24
-1.4%
-95.8%
Net Margin
ASPS
ASPS
AVDL
AVDL
Q4 25
-16.8%
Q3 25
-5.5%
0.0%
Q2 25
38.5%
14.2%
Q1 25
-12.1%
-9.4%
Q4 24
-21.3%
-10.0%
Q3 24
-23.0%
-5.2%
Q2 24
-21.1%
-33.3%
Q1 24
-23.2%
-100.6%
EPS (diluted)
ASPS
ASPS
AVDL
AVDL
Q4 25
$-1.02
Q3 25
$-0.22
$0.00
Q2 25
$1.48
$0.10
Q1 25
$-0.09
$-0.05
Q4 24
$-4.72
$-0.04
Q3 24
$-2.61
$-0.03
Q2 24
$-2.33
$-0.14
Q1 24
$-0.33
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPS
ASPS
AVDL
AVDL
Cash + ST InvestmentsLiquidity on hand
$26.6M
$91.6M
Total DebtLower is stronger
$191.1M
Stockholders' EquityBook value
$-110.2M
$98.2M
Total Assets
$139.8M
$199.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPS
ASPS
AVDL
AVDL
Q4 25
$26.6M
Q3 25
$28.6M
$91.6M
Q2 25
$30.0M
$81.5M
Q1 25
$30.8M
$66.5M
Q4 24
$29.8M
$73.8M
Q3 24
$28.3M
$65.8M
Q2 24
$29.7M
$71.4M
Q1 24
$29.6M
$88.8M
Total Debt
ASPS
ASPS
AVDL
AVDL
Q4 25
$191.1M
Q3 25
$192.5M
Q2 25
$193.9M
Q1 25
$195.0M
Q4 24
$230.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASPS
ASPS
AVDL
AVDL
Q4 25
$-110.2M
Q3 25
$-104.2M
$98.2M
Q2 25
$-102.7M
$90.7M
Q1 25
$-119.8M
$74.1M
Q4 24
$-157.4M
$73.8M
Q3 24
$-149.4M
$74.7M
Q2 24
$-140.8M
$70.3M
Q1 24
$-133.3M
$78.4M
Total Assets
ASPS
ASPS
AVDL
AVDL
Q4 25
$139.8M
Q3 25
$139.9M
$199.4M
Q2 25
$142.9M
$187.2M
Q1 25
$145.7M
$167.9M
Q4 24
$143.6M
$164.2M
Q3 24
$144.5M
$158.3M
Q2 24
$146.6M
$157.5M
Q1 24
$148.9M
$167.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPS
ASPS
AVDL
AVDL
Operating Cash FlowLast quarter
$-505.0K
$22.2M
Free Cash FlowOCF − Capex
$-525.0K
$22.2M
FCF MarginFCF / Revenue
-1.2%
28.7%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
1110.25×
TTM Free Cash FlowTrailing 4 quarters
$-5.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPS
ASPS
AVDL
AVDL
Q4 25
$-505.0K
Q3 25
$718.0K
$22.2M
Q2 25
$-306.0K
$12.7M
Q1 25
$-5.0M
$-8.2M
Q4 24
$-1.4M
$7.9M
Q3 24
$-1.6M
$-6.9M
Q2 24
$180.0K
$-18.2M
Q1 24
$-2.2M
$-29.7M
Free Cash Flow
ASPS
ASPS
AVDL
AVDL
Q4 25
$-525.0K
Q3 25
$697.0K
$22.2M
Q2 25
$-309.0K
Q1 25
$-5.0M
Q4 24
$-1.4M
Q3 24
Q2 24
Q1 24
FCF Margin
ASPS
ASPS
AVDL
AVDL
Q4 25
-1.2%
Q3 25
1.7%
28.7%
Q2 25
-0.7%
Q1 25
-11.5%
Q4 24
-3.4%
Q3 24
Q2 24
Q1 24
Capex Intensity
ASPS
ASPS
AVDL
AVDL
Q4 25
0.0%
Q3 25
0.1%
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
ASPS
ASPS
AVDL
AVDL
Q4 25
Q3 25
1110.25×
Q2 25
-0.02×
1.31×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPS
ASPS

Services$39.9M94%
Revenue Relatedto Technology Platformsand Professional Services$2.4M6%

AVDL
AVDL

Segment breakdown not available.

Related Comparisons